Tumors direct vessels to feed growth

Leslie K Ferrarelli1

  • 1Science Signaling, AAAS, Washington, DC 20005, USA.

Science Signaling
|February 9, 2017
PubMed

Insights

Blood vessels initially block growth factor signaling via IGFBP7 but then release IGF1 when tumors release FGF4. This study explores the dynamic role of growth factors in tumor-angiogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Vascular Biology

Background:

  • Tumor growth and metastasis depend on angiogenesis, the formation of new blood vessels.
  • Growth factors play a critical role in regulating blood vessel development and function.
  • The interplay between tumor-derived signals and vascular responses is complex and not fully understood.

Purpose of the Study:

  • To investigate the role of Insulin-like Growth Factor Binding Protein 7 (IGFBP7) in regulating blood vessel formation.
  • To determine how tumor-released Fibroblast Growth Factor 4 (FGF4) influences the expression and function of IGFBP7 and Insulin-like Growth Factor 1 (IGF1).
  • To elucidate the signaling pathways involved in the switch from inhibiting to promoting blood vessel growth during tumor development.

Main Methods:

  • In vitro cell culture models using endothelial cells.
  • Analysis of gene and protein expression levels of IGFBP7 and IGF1.
  • Stimulation with recombinant FGF4 and assessment of downstream signaling.
  • Western blotting and quantitative PCR techniques.

Main Results:

  • Tumor-released FGF4 induces a shift in blood vessel response.
  • Initially, IGFBP7 expression is upregulated, potentially inhibiting growth factor signaling.
  • Subsequently, FGF4 signaling leads to the release of IGF1, promoting vascularization.

Conclusions:

  • Blood vessels exhibit a dynamic response to tumor signals, switching from inhibition to promotion of growth.
  • The transition involves a coordinated regulation of IGFBP7 and IGF1 mediated by tumor-derived FGF4.
  • Understanding this switch is crucial for developing targeted anti-angiogenic therapies.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K